Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAM 2013/01 pediatric AML protocol
2014-000652-28Phase 3Completed
- Sponsor
- Italian Association of Pediatric Hematology and Oncology
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cytarabine in acute myeloid leukemia (AML), sponsored by Italian Association of Pediatric Hematology and Oncology. Primary endpoint: Event-free survival at 3 years. Started Mar 2014; status: completed.
02
Drugs
cytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on 2014-000652-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000652-28.